Premium
Heron Therapeautics Inc (HRTX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-06 | Mr. Mark E. HensleyExec. VP & COO | 125,00k | 0,00 | Derivative Exercise and Retained Stock | - | 136,77k | 1 062,02% |
| 2026-04-30 | Mr. Mark E. HensleyExec. VP & COO | 11,77k | 0,00 | Derivative Exercise and Retained Stock | - | 11,77k | - |
| 2026-04-30 | Dr. William P. ForbesExec. VP & Chief Development Officer | 23,46k | 0,00 | Derivative Exercise and Retained Stock | - | 209,11k | 12,64% |
| 2026-04-30 | Ms. Ira DuarteExec. VP & CFO | 25,23k | 0,00 | Derivative Exercise and Retained Stock | - | 252,13k | 11,12% |
| 2026-04-30 | Mr. Craig Alexander CollardCEO & Director | 84,81k | 0,00 | Derivative Exercise and Retained Stock | - | 757,89k | 12,60% |
| 2026-04-19 | Dr. William P. ForbesExec. VP & Chief Development Officer | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 185,65k | 2,13% |
| 2026-04-19 | Mr. Craig Alexander CollardCEO & Director | 13,80k | 0,00 | Derivative Exercise and Retained Stock | - | 652,58k | 2,16% |
| 2026-04-19 | Ms. Ira DuarteExec. VP & CFO | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 215,88k | 1,83% |
| 2026-04-03 | Mr. Craig Alexander CollardCEO & Director | 62,50k | 0,00 | Derivative Exercise and Retained Stock | - | 638,79k | 10,85% |
| 2026-01-31 | Ms. Ira DuarteExec. VP & CFO | 11,70k | 0,00 | Derivative Exercise and Retained Stock | - | 195,36k | 6,37% |
| 2026-01-31 | Dr. William P. ForbesExec. VP & Chief Development Officer | 11,70k | 0,00 | Derivative Exercise and Retained Stock | - | 181,77k | 6,88% |
| 2026-01-31 | Mr. Craig Alexander CollardCEO & Director | 34,79k | 0,00 | Derivative Exercise and Retained Stock | - | 571,71k | 6,48% |
| 2026-01-19 | Dr. William P. ForbesExec. VP & Chief Development Officer | 3,88k | 0,00 | Derivative Exercise and Retained Stock | - | 170,08k | 2,33% |
| 2026-01-19 | Ms. Ira DuarteExec. VP & CFO | 3,88k | 0,00 | Derivative Exercise and Retained Stock | - | 183,66k | 2,16% |
| 2026-01-19 | Mr. Craig Alexander CollardCEO & Director | 13,80k | 0,00 | Derivative Exercise and Retained Stock | - | 536,92k | 2,64% |
| 2025-10-31 | Dr. William P. ForbesExec. VP & Chief Development Officer | 11,69k | 0,00 | Derivative Exercise and Retained Stock | - | 166,20k | 7,57% |
| 2025-10-31 | Ms. Ira DuarteExec. VP & CFO | 11,69k | 0,00 | Derivative Exercise and Retained Stock | - | 179,79k | 6,96% |
| 2025-10-31 | Mr. Craig Alexander CollardCEO & Director | 34,79k | 0,00 | Derivative Exercise and Retained Stock | - | 523,12k | 7,12% |
| 2025-10-19 | Dr. William P. ForbesExec. VP & Chief Development Officer | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 154,51k | 2,57% |
| 2025-10-19 | Ms. Ira DuarteExec. VP & CFO | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 168,09k | 2,36% |
| 2025-10-19 | Mr. Craig Alexander CollardCEO & Director | 13,80k | 0,00 | Derivative Exercise and Retained Stock | - | 488,34k | 2,91% |
| 2025-10-15 | Rubric Capital Management LPSociété | 946,10k | 0,00 | Derivative Exercise and Retained Stock | - | 30,05M | 3,25% |
| 2025-08-08 | Rubric Capital Management LPSociété | 35,00M | 0,00 | Open Market Derivative Acquisition | - | 35,00M | - |
| 2025-08-08 | Rubric Capital Management LPSociété | 94,61k | 0,00 | Open Market Derivative Acquisition | - | 94,61k | - |
| 2025-08-08 | Rubric Capital Management LPSociété | 2,39M | 3,58M | Achat | 1,50 | 29,10M | 8,94% |
| 2025-08-08 | Velan Capital Partners LPSociété | 70,01k | 0,00 | Open Market Derivative Acquisition | 1,50 | 70,01k | - |
| 2025-08-08 | Velan Capital Partners LPSociété | 1,77M | 2,65M | Achat | 1,50 | 8,75M | 25,28% |
| 2025-07-31 | Dr. William P. ForbesExec. VP & Chief Development Officer | 11,70k | 0,00 | Derivative Exercise and Retained Stock | - | 150,64k | 8,42% |
| 2025-07-31 | Ms. Ira DuarteExec. VP & CFO | 11,70k | 0,00 | Derivative Exercise and Retained Stock | - | 164,22k | 7,67% |
| 2025-07-31 | Mr. Craig Alexander CollardCEO & Director | 34,79k | 0,00 | Derivative Exercise and Retained Stock | - | 474,54k | 7,91% |
| 2025-07-19 | Dr. William P. ForbesExec. VP & Chief Development Officer | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 138,94k | 2,87% |
| 2025-07-19 | Ms. Ira DuarteExec. VP & CFO | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 152,52k | 2,61% |
| 2025-07-19 | Mr. Craig Alexander CollardCEO & Director | 13,80k | 0,00 | Derivative Exercise and Retained Stock | - | 439,75k | 3,24% |
| 2025-06-16 | Ms. Ira DuarteExec. VP & CFO | 12,50k | 0,00 | Derivative Exercise and Retained Stock | - | 148,65k | 9,18% |
| 2025-06-06 | Dr. William P. ForbesExec. VP & Chief Development Officer | 12,50k | 0,00 | Derivative Exercise and Retained Stock | - | 135,07k | 10,20% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
